LigaChem Biosciences, Inc.

141080 · KOSDAQ · South Korea

Public Market Listing

141080KOSDAQ

KOSDAQ primary exchange listing

Live quotes, historical charts, and market capitalization for LigaChem Biosciences, Inc. are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
1Diseases
Showing 2 of 2 assets
Target & Modality
Phase 1/2
TROP2Antibody–drug conjugate
Non-Small Cell Lung Cancer
Phase 1
B7-H4Antibody–drug conjugate
Non-Small Cell Lung Cancer

Upcoming events

(1 total)

Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (1)
January 2027 (1)
LCB84Phase 1/2Advanced Solid Tumors
Est. primary completion 2027-01 · NCT05941507 · CT.gov ↗
What to watch

See the full readout calendar ↗

Financial reports

No financial reports recorded.